Adaptive Biotechnologies Long Term Deferred Charges (Quarterly) Analysis

Adaptive Biotechnologies Corp. (ADPT)

15.87 -0.09 (-0.56%) USD | NASDAQ | Jan 09, 13:58

View Long Term Deferred Charges (Quarterly) for ADPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Zymeworks, Inc.	--
Cue Biopharma, Inc.	--
Recursion Pharmaceuticals, Inc.	--
Arcellx, Inc.	--